Tomocube토모큐브
475960 · KOSDAQ · ₩475960 · 토모큐브
- Market cap
- ₩423B
- Enterprise value
- ₩396B
- P/E
- —
- P/B
- 11.2×
- Dividend yield
- 0.0%
- ROE
- −6.5%
- Net margin
- −16.1%
Trailing 12 months from filed financial statements, as of H1 2026. Dividend yield: the 2025 dividend per share from the annual report ÷ today's price.
52-week range−53.7% from the high
₩26,000Today: ₩31,350 – ₩33,000₩67,800
Returns
- 1W+3.0%
- 1M+12.7%
- 3M−0.2%
- 6M−41.6%
- YTD−38.4%
- 1Y−25.9%
- Volume today
- 37,368
- 0.7× the 20-day average
- Traded today
- ₩1.2B
- Listed shares
- 13,476,174
- EPS (12 months)
- −₩182
- Earnings yield −0.6%
Upcoming dates
Full calendar →🎁 Gift this stock
Send a friend ₩100,000 of paper money in this stock. They get it when they join.
Signals
Quiet- BuzzQuietBuzz 41 of 100 (50 is a normal day for this stock).
- MomentumFlat15% over the last month; the price is below its 20-day average.
Signals describe activity, not recommendations. Not financial advice.
Tomocube stock overview
Tomocube (토모큐브, KRX: 475960) is listed on KOSDAQ, in the Medical & precision devices sector. The company develops holotomography-based advanced cell imaging instruments, such as the HT-X1, for biomedical research and diagnostics, and sells HT product lines along with consumables, software, and warranty services. Its shares closed at ₩31,400 on Oct 27, 2026, up 0.16% on the day, giving it a market value of ₩423B.
Key facts
- Market cap
- ₩423B
- Sector
- Medical & precision devices
- Latest price change
- +0.16%
- As of
- Oct 27, 2026
- Main business
- The company develops holotomography-based advanced cell imaging instruments, such as the HT-X1, for biomedical research and diagnostics, and sells HT product lines along with consumables, software, and warranty services.
Quick answers about Tomocube
- What does Tomocube do?
- The company develops holotomography-based advanced cell imaging instruments, such as the HT-X1, for biomedical research and diagnostics, and sells HT product lines along with consumables, software, and warranty services. Its products are used by more than 200 institutions in over 50 countries, including universities and research institutes, and by companies in the biomedical field. The company operates through direct sales from its headquarters and subsidiaries in the United States and Europe, along with distributors, and most of its revenue comes from exports.
- What is the market cap of Tomocube?
- The market capitalisation of Tomocube was ₩423B at the close on Oct 27, 2026.
- Who are the largest shareholders of Tomocube?
- According to the latest official filings, the largest reported holders are Park Yong-geun (27.34%, as of May 28, 2026); Interbest (12.65%, as of Jan 23, 2025); Hong Ki-hyeon (7.85%, as of Nov 13, 2024).
- When is the next earnings report from Tomocube?
- Korean companies rarely announce results dates in advance. Based on when Tomocube filed the same report in past years, its next 3q results is expected around Nov 14, 2026.
- Does the National Pension Service own Tomocube?
- Yes. The National Pension Service held 0.89% of Tomocube shares as of Dec 31, 2025.
Company profile
The company develops holotomography-based advanced cell imaging instruments, such as the HT-X1, for biomedical research and diagnostics, and sells HT product lines along with consumables, software, and warranty services. Its products are used by more than 200 institutions in over 50 countries, including universities and research institutes, and by companies in the biomedical field. The company operates through direct sales from its headquarters and subsidiaries in the United States and Europe, along with distributors, and most of its revenue comes from exports.
Written by AI from the company's latest annual report.
- Korean name
- 토모큐브
- CEO
- 박용근
- Founded
- Aug 2015
- Listed
- Nov 2024
- Listed shares
- 13,476,174
- Fiscal year ends
- Month 12
- Website
- www.tomocube.com
Similar companies
- TSE131290 · ₩2.9T₩260,000+7.88%
- Kctech281820 · ₩1.8T₩91,900+6.37%
- Classys214150 · ₩1.7T₩26,500−2.57%
- Park Systems140860 · ₩1.6T₩225,500+1.12%
- Curiox Biosystems445680 · ₩1.1T₩62,300+6.13%
- DI003160 · ₩1.1T₩37,800+4.71%
- Seers458870 · ₩1T₩26,300−5.57%
- LivsMed491000 · ₩937B₩37,100+1.50%
Recent filings
See all- Investor relations (IR) eventAug 20, 2026
- Half-year report (Jun 2026)Aug 14, 2026
- Insider shareholding reportJul 15, 2026
- 5%+ holding reportMay 28, 2026
- Investor relations (IR) eventMay 15, 2026
Titles in Korean until English translations are added.
Also known as: Tomocube / 토모큐브 / 475960 / KRX:475960
Source: KRX statistical information